slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 31,261-31,290
Pages 1,935
Rows per page 30
Slide function
31,261-31,290 of 58,039
52
The slide highlights the efficacy of MGL-3196 in NASH treatment using MRI-PDFF as a biomarker.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
53
Figure 3 from Stine JG, Munaganuru. Clin Gastroenterol Hepatol. 2021 Nov.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
55
The table compares Placebo, AXA1125 22.6 BID, and AXA1125 33.9 BID groups.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
24
The chart combines a line graph for expense trends and a vertical bar for a specific event marker.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · The Breakthrough1 hit
25
The chart shows a significant drop in expenses following the Q3 2021 'New Team Start Date'.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · The Breakthrough1 hit
26
The chart shows a downward trend in G&A expenses following the Q3 2021 team start date.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations 1 hit
22
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
24
Includes a comparison of Q2 2021 vs Q2 2022 and H1 2021 vs H1 2022.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
12
The slide uses two charts to demonstrate market validation: one for investment growth and one for pipeline expansion.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle1 hit
23
The chart uses a timeline-style progression (Hit to Lead through Phase III) to visualize drug development status.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
30
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
41
The chart uses a swimlane-style visualization to show progress across drug discovery stages (Target ID to Phase III).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
48
Includes specific caveats regarding small sample size and short duration.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
53
The slide demonstrates the inhibitory effect of anti-TNF monoclonal antibodies on cytokine release.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
54
The slide displays protein phosphorylation intensity across various markers for healthy vs. inflamed tissue.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
55
The slide contains four dose-response curves (a-d) and two box-and-whisker plots (e-f) showing cytokine levels in patient biopsies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
67
The table shows financial results for the six months ended 30 June 2022 vs 2021. Expenses are shown in parentheses indicating negative values.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
68
The slide explains the impact of non-recurring business combination costs on the operating loss.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
69
The slide reconciles operating loss to cash expended from underlying operating activities and shows the movement in cash balance.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
04
The chart illustrates the market reaction to the Rio Tinto offer, showing the initial premium and the current premium relative to the peer group index.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Pattern Hunter1 hit
06
The chart uses a stacked bar format for later years to distinguish between GoM dividends and TRQ cash flows.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
09
The chart overlays transaction events (producers vs developers) onto a historical copper price time series.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
10
The table compares initial and revised proposal premiums against a range of future P/NAV multiples to calculate potential IRR.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & Proof1 hit
11
The slide uses a waterfall-style chart to compare valuation ranges across different methodologies, with a clear distinction between 'Core Methodologies' and 'Informational Purposes'.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank 1 hit
13
MI 61-101 refers to Multilateral Instrument 61-101, a Canadian regulatory standard for protection of minority security holders in special transactions.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
15
The slide shows a waterfall-style calculation of NAVPS, starting from Oyu Tolgoi NPV down to TRQ's final NAVPS in both USD and CAD.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
16
The chart compares target prices from five different financial institutions (Eight, Canaccord, Scotia, Macquarie, TD) with their respective recommendations and dates.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
22
Includes detailed footnotes explaining the methodology for WACC and beta calculations.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
15
The slide uses a three-column layout with metrics paired with lifestyle and product imagery.Boohoo | Results Presentation Deck | 41 slides · boohoo group plc
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
19
The slide presents two tables: a primary income statement summary and a secondary table for adjusting items, accompanied by four callout boxes explaining the financial performance.Boohoo | Results Presentation Deck | 41 slides · boohoo group plc
Conference presentation Investor relations Beat · Action1 hit